Intramuscular Drug Delivery Market, Global Outlook and Forecast 2023-2029

Report ID: MMG142803 | Category: Service & Software | Pages: 67 | Format: PDF | Published Date: July 21,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Intramuscular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Drug Delivery. This report contains market size and forecasts of Intramuscular Drug Delivery in global, including the following market information:
Global Intramuscular Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Intramuscular Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drug Molecule Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intramuscular Drug Delivery include Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intramuscular Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intramuscular Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Intramuscular Drug Delivery Market Segment Percentages, by Type, 2022 (%)
    Drug Molecule
    Delivery Devices
Global Intramuscular Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Intramuscular Drug Delivery Market Segment Percentages, by Application, 2022 (%)
    Infectious Disease
    Oncology
    Autoimmune Diseases
Global Intramuscular Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Intramuscular Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intramuscular Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Intramuscular Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Antares Pharma
    Eli Lily
    Galaxo
    HMD pharmaceuticals
    Inovio Pharmaceuticals
    Merck
    Novartis
    Pacira Pharmaceuticals
    Pfizer
    Pharmajet
    Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intramuscular Drug Delivery, market overview.
Chapter 2: Global Intramuscular Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Intramuscular Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intramuscular Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Intramuscular Drug Delivery Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Intramuscular Drug Delivery Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Intramuscular Drug Delivery Overall Market Size
    2.1 Global Intramuscular Drug Delivery Market Size: 2022 VS 2029
    2.2 Global Intramuscular Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Intramuscular Drug Delivery Players in Global Market
    3.2 Top Global Intramuscular Drug Delivery Companies Ranked by Revenue
    3.3 Global Intramuscular Drug Delivery Revenue by Companies
    3.4 Top 3 and Top 5 Intramuscular Drug Delivery Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Intramuscular Drug Delivery Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Intramuscular Drug Delivery Players in Global Market
        3.6.1 List of Global Tier 1 Intramuscular Drug Delivery Companies
        3.6.2 List of Global Tier 2 and Tier 3 Intramuscular Drug Delivery Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Intramuscular Drug Delivery Market Size Markets, 2022 & 2029
        4.1.2 Drug Molecule
        4.1.3 Delivery Devices
    4.2 By Type - Global Intramuscular Drug Delivery Revenue & Forecasts
        4.2.1 By Type - Global Intramuscular Drug Delivery Revenue, 2018-2023
        4.2.2 By Type - Global Intramuscular Drug Delivery Revenue, 2024-2029
        4.2.3 By Type - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Intramuscular Drug Delivery Market Size, 2022 & 2029
        5.1.2 Infectious Disease
        5.1.3 Oncology
        5.1.4 Autoimmune Diseases
    5.2 By Application - Global Intramuscular Drug Delivery Revenue & Forecasts
        5.2.1 By Application - Global Intramuscular Drug Delivery Revenue, 2018-2023
        5.2.2 By Application - Global Intramuscular Drug Delivery Revenue, 2024-2029
        5.2.3 By Application - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Intramuscular Drug Delivery Market Size, 2022 & 2029
    6.2 By Region - Global Intramuscular Drug Delivery Revenue & Forecasts
        6.2.1 By Region - Global Intramuscular Drug Delivery Revenue, 2018-2023
        6.2.2 By Region - Global Intramuscular Drug Delivery Revenue, 2024-2029
        6.2.3 By Region - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Intramuscular Drug Delivery Revenue, 2018-2029
        6.3.2 US Intramuscular Drug Delivery Market Size, 2018-2029
        6.3.3 Canada Intramuscular Drug Delivery Market Size, 2018-2029
        6.3.4 Mexico Intramuscular Drug Delivery Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Intramuscular Drug Delivery Revenue, 2018-2029
        6.4.2 Germany Intramuscular Drug Delivery Market Size, 2018-2029
        6.4.3 France Intramuscular Drug Delivery Market Size, 2018-2029
        6.4.4 U.K. Intramuscular Drug Delivery Market Size, 2018-2029
        6.4.5 Italy Intramuscular Drug Delivery Market Size, 2018-2029
        6.4.6 Russia Intramuscular Drug Delivery Market Size, 2018-2029
        6.4.7 Nordic Countries Intramuscular Drug Delivery Market Size, 2018-2029
        6.4.8 Benelux Intramuscular Drug Delivery Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Intramuscular Drug Delivery Revenue, 2018-2029
        6.5.2 China Intramuscular Drug Delivery Market Size, 2018-2029
        6.5.3 Japan Intramuscular Drug Delivery Market Size, 2018-2029
        6.5.4 South Korea Intramuscular Drug Delivery Market Size, 2018-2029
        6.5.5 Southeast Asia Intramuscular Drug Delivery Market Size, 2018-2029
        6.5.6 India Intramuscular Drug Delivery Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Intramuscular Drug Delivery Revenue, 2018-2029
        6.6.2 Brazil Intramuscular Drug Delivery Market Size, 2018-2029
        6.6.3 Argentina Intramuscular Drug Delivery Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Intramuscular Drug Delivery Revenue, 2018-2029
        6.7.2 Turkey Intramuscular Drug Delivery Market Size, 2018-2029
        6.7.3 Israel Intramuscular Drug Delivery Market Size, 2018-2029
        6.7.4 Saudi Arabia Intramuscular Drug Delivery Market Size, 2018-2029
        6.7.5 UAE Intramuscular Drug Delivery Market Size, 2018-2029
7 Intramuscular Drug Delivery Companies Profiles
    7.1 Antares Pharma
        7.1.1 Antares Pharma Company Summary
        7.1.2 Antares Pharma Business Overview
        7.1.3 Antares Pharma Intramuscular Drug Delivery Major Product Offerings
        7.1.4 Antares Pharma Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.1.5 Antares Pharma Key News & Latest Developments
    7.2 Eli Lily
        7.2.1 Eli Lily Company Summary
        7.2.2 Eli Lily Business Overview
        7.2.3 Eli Lily Intramuscular Drug Delivery Major Product Offerings
        7.2.4 Eli Lily Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.2.5 Eli Lily Key News & Latest Developments
    7.3 Galaxo
        7.3.1 Galaxo Company Summary
        7.3.2 Galaxo Business Overview
        7.3.3 Galaxo Intramuscular Drug Delivery Major Product Offerings
        7.3.4 Galaxo Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.3.5 Galaxo Key News & Latest Developments
    7.4 HMD pharmaceuticals
        7.4.1 HMD pharmaceuticals Company Summary
        7.4.2 HMD pharmaceuticals Business Overview
        7.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Major Product Offerings
        7.4.4 HMD pharmaceuticals Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.4.5 HMD pharmaceuticals Key News & Latest Developments
    7.5 Inovio Pharmaceuticals
        7.5.1 Inovio Pharmaceuticals Company Summary
        7.5.2 Inovio Pharmaceuticals Business Overview
        7.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Major Product Offerings
        7.5.4 Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.5.5 Inovio Pharmaceuticals Key News & Latest Developments
    7.6 Merck
        7.6.1 Merck Company Summary
        7.6.2 Merck Business Overview
        7.6.3 Merck Intramuscular Drug Delivery Major Product Offerings
        7.6.4 Merck Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.6.5 Merck Key News & Latest Developments
    7.7 Novartis
        7.7.1 Novartis Company Summary
        7.7.2 Novartis Business Overview
        7.7.3 Novartis Intramuscular Drug Delivery Major Product Offerings
        7.7.4 Novartis Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.7.5 Novartis Key News & Latest Developments
    7.8 Pacira Pharmaceuticals
        7.8.1 Pacira Pharmaceuticals Company Summary
        7.8.2 Pacira Pharmaceuticals Business Overview
        7.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Major Product Offerings
        7.8.4 Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.8.5 Pacira Pharmaceuticals Key News & Latest Developments
    7.9 Pfizer
        7.9.1 Pfizer Company Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Intramuscular Drug Delivery Major Product Offerings
        7.9.4 Pfizer Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.9.5 Pfizer Key News & Latest Developments
    7.10 Pharmajet
        7.10.1 Pharmajet Company Summary
        7.10.2 Pharmajet Business Overview
        7.10.3 Pharmajet Intramuscular Drug Delivery Major Product Offerings
        7.10.4 Pharmajet Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.10.5 Pharmajet Key News & Latest Developments
    7.11 Teva Pharmaceutical
        7.11.1 Teva Pharmaceutical Company Summary
        7.11.2 Teva Pharmaceutical Business Overview
        7.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Major Product Offerings
        7.11.4 Teva Pharmaceutical Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
        7.11.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Intramuscular Drug Delivery Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?